Ginkgo Bioworks Files Q1 2025 10-Q
Ticker: DNABW · Form: 10-Q · Filed: May 6, 2025 · CIK: 1830214
| Field | Detail |
|---|---|
| Company | Ginkgo Bioworks Holdings, Inc. (DNABW) |
| Form Type | 10-Q |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotechnology, financials
TL;DR
Ginkgo Bioworks Q1 2025 10-Q is in. Check financials for Cell Engineering & Biosecurity segments.
AI Summary
Ginkgo Bioworks Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Soaring Eagle Acquisition Corp., reported financial results for the first quarter of 2025. Key financial data and segment revenues, including Cell Engineering and Biosecurity, are detailed within the filing.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Ginkgo Bioworks, crucial for understanding the company's trajectory in the biotechnology sector.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information and forward-looking statements that inherently carry investment risk.
Key Numbers
- Q1 2025 — Reporting Period (First quarter financial results)
- 2025-03-31 — Period End Date (Marks the end of the financial reporting quarter)
- 2024-12-31 — Previous Period End Date (Provides a comparison point for financial changes)
Key Players & Entities
- Ginkgo Bioworks Holdings, Inc. (company) — Filer of the 10-Q
- Soaring Eagle Acquisition Corp. (company) — Former name of Ginkgo Bioworks Holdings, Inc.
- 20250331 (date) — End of the reporting period
- 20250506 (date) — Filing date
FAQ
What were the total revenues for the Cell Engineering segment in Q1 2025?
The filing indicates 'dna:CellEngineeringRevenueMember' for the period 2025-01-01 to 2025-03-31, but specific dollar amounts are not provided in this header snippet.
What is the company's primary industry classification?
Ginkgo Bioworks Holdings, Inc. is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]'.
When did the company change its name from Soaring Eagle Acquisition Corp.?
The name change from Soaring Eagle Acquisition Corp. to Ginkgo Bioworks Holdings, Inc. occurred on 20210210.
What is the fiscal year end for Ginkgo Bioworks?
The fiscal year end for Ginkgo Bioworks Holdings, Inc. is December 31 (1231).
What is the filing date of this 10-Q report?
This 10-Q report was filed on 20250506.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding Ginkgo Bioworks Holdings, Inc. (DNABW).